2019
DOI: 10.14283/jpad.2019.32
|View full text |Cite
|
Sign up to set email alerts
|

Can Digital Technology Advance the Development of Treatments for Alzheimer’s Disease?

Abstract: The report explores the potential digital technology has to generate novel endpoints and digital biomarkers for Alzheimer’s disease drug development studies. Drawing from literature and novel pilots, we explore the value of innovative digital technology to digitize physiological behaviours such as sleep disturbance and gait changes. Technology now exists to monitor and quantify our use and interaction with electronics in the home, the use of social platforms and smart-phones, geolocation, sleep and activity p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
1
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(14 citation statements)
references
References 16 publications
0
14
0
Order By: Relevance
“…Passive monitoring with digital tools that measure gait, sleep, tremor, word cadence, and location might also be explored as novel endpoints. Digital tools, unlike other COAs, more intimately adhere to the patient's experience and could reveal meaningful and relevant treatment effects that go unobserved in everyday life 60 …”
Section: Discussionmentioning
confidence: 99%
“…Passive monitoring with digital tools that measure gait, sleep, tremor, word cadence, and location might also be explored as novel endpoints. Digital tools, unlike other COAs, more intimately adhere to the patient's experience and could reveal meaningful and relevant treatment effects that go unobserved in everyday life 60 …”
Section: Discussionmentioning
confidence: 99%
“…These healthcare solutions may include elderly care [9], remote healthcare [10], fitness programs [11], detection and prognosis of neurological and mental disorders like Alzheimer, epilepsy, autism spectrum disorder and schizophrenia, etc. [12][13][14][15][16][17]. Deep learning [18] is another paradigm in this regard, which is capable of handling the large volume of signal data generated by wearable IoT sensing devices like EEG headsets for epilepsy [19].…”
Section: Introductionmentioning
confidence: 99%
“…Currently, speech recording for AD-related research typically takes place in a quiet room with a guiding clinician. Given that smartphone technology is rapidly advancing, speech assessments using ML models trained on recordings obtained by smartphones offer a potentially simple-to-administer and inexpensive solution, scalable to the entire population, that can be performed anywhere, including the patient's home [8,9,10]. However, the problem of model robustness to acoustic noise becomes increasingly important when deploying ML models in real world [11].…”
Section: Introductionmentioning
confidence: 99%